Protalix BioTherapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.

About PLX

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11.

CEO

Dror Bashan

CEODror Bashan

Employees

213

Employees213

Headquarters

Hackensack, New Jersey

HeadquartersHackensack, New Jersey

Founded

1993

Founded1993

Employees

213

Employees213

PLX Key Statistics

Market cap

222.00M

Market cap222.00M

Price-Earnings ratio

80.33

Price-Earnings ratio80.33

Dividend yield

—

Dividend yield—

Average volume

755.15K

Average volume755.15K

High today

$3.07

High today$3.07

Low today

$2.84

Low today$2.84

Open price

$3.01

Open price$3.01

Volume

797.51K

Volume797.51K

52 Week high

$3.07

52 Week high$3.07

52 Week low

$0.8214

52 Week low$0.8214

Protalix BioTherapeutics

Why Robinhood?

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. Show more

PLX Key Statistics

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11.